本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

51.80
-0.2200-0.42%
盘后:51.800.00000.00%16:10 EDT
成交量:166.86万
成交额:8,671.28万
市值:48.83亿
市盈率:-108.72
高:52.81
开:51.57
低:51.38
收:52.02
52周最高:68.73
52周最低:22.59
股本:9,426.11万
流通股本:9,276.71万
量比:0.77
换手率:1.80%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
净资产收益率:-236.35%
总资产收益率:-3.73%
市净率:199.12
市盈率(LYR):-180.90

数据加载中...

2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/07/09

重要事件披露

Form 8-K - Current report
2026/06/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/16

重要事件披露

Form 8-K - Current report
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/02

重要事件披露

Form 8-K - Current report
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities